EUVIMEDEUVIMED entdecken
Fallbericht

Hypercalcemia of malignancy: Cancer treatment can be a cause as well

Hassan Izzedine, Rose Mary Attieh, Farhana Begum, Yee-Ming Melody Cheung, Kenar D Jhaveri

Clinical Nephrology · 2024

DOI: 10.5414/cn111403 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Nephrology, 2024. Verfasst von Hassan Izzedine und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hypercalcemia, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While the incidence of hypercalcemia of malignancy (HCM) is on the decline, it still occurs in up to 30% of patients with cancer. Immune checkpoint inhibitor (ICI)-related hypercalcemia is becoming increasingly recognized. We describe a case of cemiplimab-induced hypercalcemia in a patient with metastatic squamous cell carcinoma of the earlobe and discuss a management algorithm for HCM. Timely diagnosis and management of HCM is critical for optimal care and the prevention of complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercalcemiaCarcinoma, Squamous CellHumansMaleImmune Checkpoint InhibitorsMiddle AgedSkin Neoplasms

Substanzen

Immune Checkpoint Inhibitors

Zitieren

APA

Izzedine, H., Attieh, R. M., Begum, F., Cheung, Y. M., & Jhaveri, K. D. (2024). Hypercalcemia of malignancy: Cancer treatment can be a cause as well. Clinical Nephrology. https://doi.org/10.5414/cn111403

Vancouver

Izzedine H, Attieh RM, Begum F, Cheung YM, Jhaveri KD. Hypercalcemia of malignancy: Cancer treatment can be a cause as well. Clinical Nephrology. 2024. doi:10.5414/cn111403

BibTeX
@article{Izzedine2024,
  author = {Izzedine, Hassan and Attieh, Rose Mary and Begum, Farhana and Cheung, Yee-Ming Melody and Jhaveri, Kenar D},
  title = {Hypercalcemia of malignancy: Cancer treatment can be a cause as well},
  journal = {Clinical Nephrology},
  year = {2024},
  doi = {10.5414/cn111403}
}
Kostenlos starten →